FaceOf: Homam Hashem, CEO of Saudi Arabia's Kafalah Fund

Homam Hashem
Updated 25 September 2018
Follow

FaceOf: Homam Hashem, CEO of Saudi Arabia's Kafalah Fund

  • Hashem studied computer information systems, receiving his bachelor’s degree from King Fahd University of Petroleum and Minerals in 1992
  • He began his career in 1993 as a systems analyst and programmer at the head office of the Banque Saudi Fransi in Riyadh

Homam Hashem is the chief executive officer at the Kafalah Fund, a financing guarantee program for small- and medium-sized enterprises.

On Saudi’s 88th National Day, Hashem elaborated on the importance of the Kafalah Fund and how supporting SMEs contributes to the economic reform of the Kingdom in accordance with Vision 2030. 

He said: “One of the main objectives of Vision 2030 is to increase the contribution of the SME private sector to 35 percent of GDP.” He pointed out that small and medium enterprises play an important role in raising financing opportunities and pave the ways to success.

Hashem studied computer information systems, receiving his bachelor’s degree from King Fahd University of Petroleum and Minerals in 1992. He also holds a diploma in banking operation management from the Institute of Public Administration.

He began his career in 1993 as a systems analyst and programmer at the head office of the Banque Saudi Fransi in Riyadh. A year later, he joined Samba Financial Group as a credit MIS senior manager for four years before moving on to Al-Rajhi Bank to occupy another senior manager post.

Hashem then spent five years simultaneously working for the Arab National Bank as a cards credit cycle manager, and Visa as a risk adviser. From there, he became Al-Yusr Leasing and Financing’s chief operations officer from 2005 to 2013. 

In 2015, he served as chief operations officer at Tayseer Arabian Co. before returning to Al-Yusr as chief credit and collection director.

He served as a board member at Al-Farasha Financial Services and the engineering solutions company ATMATA.


Saudi hospital pioneers preventive type 1 diabetes treatment

KFSH&RC has introduced a groundbreaking preventive treatment aimed at slowing the progression of type 1 diabetes. (SPA)
Updated 59 min 11 sec ago
Follow

Saudi hospital pioneers preventive type 1 diabetes treatment

  • The new therapy is designed for adults and children aged eight years and older who are diagnosed at stage two of the disease

RIYADH: King Faisal Specialist Hospital and Research Center introduced a groundbreaking preventive treatment aimed at slowing the progression of type 1 diabetes, the Saudi Press Agency reported on Wednesday.
The new therapy is designed for adults and children aged eight years and older who are diagnosed at stage two of the disease. It marks the first time such a treatment has been implemented in the Kingdom.
The initial application involved two patients who met all the criteria outlined in the approved protocol. The step represents a major advance in early preventive care for one of the most common autoimmune conditions affecting children and adolescents.
Both cases were treated at the hospital’s Department of Pediatrics. For families already managing type 1 diabetes, the innovation brings new hope.
Siblings of affected children often face increased risk due to shared genetic and immune factors. Preventive options like this could significantly lower those risks in the future.
The treatment targets the early, pre-type 1 diabetes stage when insulin-producing pancreatic cells begin to deteriorate. Through early intervention, doctors can slow this damage, delay the onset of symptoms and help extend the time before full disease progression.
Implementing the therapy required careful preparation. The drug was compounded in the hospital pharmacy under a precise protocol, while nursing teams received training on administration, monitoring and managing possible reactions.
Medical staff were also briefed on patient selection and follow-up criteria based on the latest clinical guidelines.
According to the SPA, experts expect the program to inspire national research focused on the early stages of the disease and on developing preventive approaches that enhance quality of life for at-risk groups.
KFSH&RC continues to gain recognition on the global stage. It was ranked first in the Middle East and Africa, and 15th worldwide among the top 250 academic medical centers for 2025.
The hospital was also named the most valuable healthcare brand in Saudi Arabia and the Middle East by Brand Finance 2025.
Additionally, Newsweek included KFSH&RC on its lists of the World’s Best Hospitals (2025), the World’s Smartest Hospitals (2026) and the World’s Best Specialized Hospitals (2026).